73
Views
8
CrossRef citations to date
0
Altmetric
Clinical Research Articles

One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms

, , , , &
Pages 199-205 | Received 20 Aug 2008, Published online: 09 Jul 2009

References

  • Abrams P. New words for old: lower urinary tract symptoms for “prostatism”. Br Med J 1994; 308: 929–30
  • Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993; 150: 351–8
  • Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. Eur Urol 2002; 42: 323–8
  • Kunelius P, Hakkinen J, Lukkarinen O. Sexual functions in patients with benign prostatic hyperplasia before and after transurethral resection of the prostate. Urol Res 1998; 26: 7–9
  • Leliefeld HH, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 208–13
  • Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995 Jan 12;332:75–9.
  • Jolleys J, Donovan JL, Nachahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they?. Br J Urol 1994; 74: 551–5
  • Barry MJ, Fowler FJ Jr, Bin L, Pitts JC III, Harris CJ, Mulley AG Jr. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 1997;157:10–4; Discussion 4–5.
  • Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158: 481–7
  • Simpson RJ, Fisher W, Lee AJ, Russell EB, Garraway M. Benign prostatic hyperplasia in an unselected community-based population: a survey of urinary symptoms, bothersomeness and prostatic enlargement. Br J Urol 1996; 77: 186–91
  • Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-“BPH” Study. International Continence Society–Benign Prostatic Hyperplasia. Br J Urol 1997; 80: 712–21
  • Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001; 166: 563–8
  • Haltbakk J, Hanestad BR, Hunskaar S. Diversity of urinary symptoms in patients tentatively diagnosed with benign prostatic hyperplasia referred to a urologic clinic in Norway. Scand J Urol Nephrol 2004; 38: 454–61
  • Jacobsen SJ, Girman CJ, Guess HA, Panser LA, Chute CG, Oesterling JE, et al. Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology 1993; 42: 663–71
  • Herzog AR, Fultz NH, Normolle DP, Brock BM, Diokno AC. Methods used to manage urinary incontinence by older adults in the community. J Am Geriatr Soc 1989; 37: 339–47
  • Peake S, Manderson L, Potts H. “Part and parcel of being a woman”: female urinary incontinence and constructions of control. Med Anthropol Q 1999; 13: 267–85
  • Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760–6
  • Engstrom G, Walker-Engstrom ML, Henningsohn L, Loof L, Leppert J. Prevalence of distress and symptom severity from the lower urinary tract in men: a population-based study with the DAN-PSS questionnaire. Fam Pract 2004; 21: 617–22
  • Engstrom G, Walker-Engstrom ML, Loof L, Leppert J. Prevalence of three lower urinary tract symptoms in men – a population-based study. Fam Pract 2003; 20: 7–10
  • van Venrooij GE, van Melick HH, Eckhardt MD, Boon TA. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams–Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2008; 71: 469–74
  • Hernandez C, Estivill E, Prieto M, Badia X. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Curr Med Res Opin 2008; 24: 1033–8
  • Seki N, Yunoki T, Tomoda T, Takei M, Yamaguchi A, Naito S. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate. Neurourol Urodyn 2008; 27: 222–5
  • Bergdahl S, Aus G, Lodding P, Norlen L, Hugosson J. Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate. Urology 1999; 53: 926–30
  • Witjes WP, de la Rosette JJ, Donovan JL, Peters TJ, Abrams P, Kay HE, et al. The International Continence Society “Benign Prostatic Hyperplasia” Study: international differences in lower urinary tract symptoms and related bother. J Urol 1997; 157: 1295–300
  • Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, et al. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 2003; 61: 1086–91
  • Pearson JD, Lei HH, Beaty TH, Wiley KE, Isaacs SD, Isaacs WB, et al. Familial aggregation of bothersome benign prostatic hyperplasia symptoms. Urology 2003; 61: 781–5
  • Roberts RO, Rhodes T, Panser LA, Girman CJ, Chute CG, Guess HA, et al. Association between family history of benign prostatic hyperplasia and urinary symptoms: results of a population-based study. Am J Epidemiol 1995; 142: 965–73
  • Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999; 8: 29–36
  • Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151–8
  • Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 2004; 172: 1390–3
  • Hammarsten J, Damber JE, Karlsson M, Knutson T, Ljunggren O, Ohlsson C, Peeker R, Smith U, Mellström D. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2008. Epub ahead of print.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.